4//SEC Filing
Liu Joy 4
Accession 0000899243-22-016320
CIK 0000875320other
Filed
May 2, 8:00 PM ET
Accepted
May 3, 4:28 PM ET
Size
12.1 KB
Accession
0000899243-22-016320
Insider Transaction Report
Form 4
Liu Joy
SVP, General Counsel
Transactions
- Sale
Common Stock
2022-04-29$274.75/sh−41$11,265→ 14,396 total - Sale
Common Stock
2022-04-29$273.37/sh−17$4,647→ 14,437 total - Sale
Common Stock
2022-04-29$275.62/sh−30$8,269→ 14,366 total - Sale
Common Stock
2022-04-29$278.04/sh−10$2,780→ 14,334 total - Sale
Common Stock
2022-04-29$276.72/sh−22$6,088→ 14,344 total
Footnotes (6)
- [F1]Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1.
- [F2]Ms. Liu undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price.
- [F3]Open market sales reported on this line occurred at a weighted average price of $273.37 (range $273.13 to $273.87).
- [F4]Open market sales reported on this line occurred at a weighted average price of $274.74 (range $274.20 to $275.14).
- [F5]Open market sales reported on this line occurred at a weighted average price of $275.62 (range $275.22 to $276.19).
- [F6]Open market sales reported on this line occurred at a weighted average price of $276.72 (range $276.31 to $277.06).
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeother
Related Parties
1- filerCIK 0001847529
Filing Metadata
- Form type
- 4
- Filed
- May 2, 8:00 PM ET
- Accepted
- May 3, 4:28 PM ET
- Size
- 12.1 KB